Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they have expanded their usage of mint Lesion™ over the years, how it has changed their clinical studies, and his view on the potential of structured data for research.
Potential of using structured data from clinical trials and routine for AI and radiomics research
Related Resources

Radiologic Recurrence Criteria for Adjuvant Clinical Trials in Bladder Cancer
After radical surgery, there is no measurable disease left to follow. A consensus framework defines when a finding on a surveillance scan counts as…
Read more

Consistent Glioma MRI Reporting with mint Lesion
In neuro-oncology, imaging assessments directly shape treatment decisions. For example, under RANO 2.0, whether a follow-up MRI is classified as…
Read more

RACOON in the Network University Medicine – Ralf Heyder on collaborative imaging research
How Germany’s university hospitals built a shared platform for radiological imaging data, and what comes next
In early October 2026, representatives…
Read more
